NasdaqGM - Delayed Quote USD
Merus N.V. (MRUS)
50.01
-0.79
(-1.56%)
At close: May 28 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-237,908
-185,835
-142,207
-149,899
-59,627
Investing Cash Flow
-216,858
-220,222
-27,020
2,802
-146,623
Financing Cash Flow
470,595
494,008
230,086
58,739
281,955
End Cash Position
194,754
294,031
205,014
148,439
241,749
Income Tax Paid Supplemental Data
--
2,800
3,103
0
635
Capital Expenditure
-1,938
-1,830
-3,982
-7,639
-870
Issuance of Capital Stock
434,863
457,476
225,945
57,740
265,107
Free Cash Flow
-239,846
-187,665
-146,189
-157,538
-60,497
12/31/2021 - 5/19/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMNN Imunon, Inc.
1.5200
-33.04%
TNXP Tonix Pharmaceuticals Holding Corp.
37.69
+1.89%
VIGL Vigil Neuroscience, Inc.
7.89
+0.13%
SPRO Spero Therapeutics, Inc.
2.3500
+244.57%
RCKT Rocket Pharmaceuticals, Inc.
2.4800
+6.44%
BCAX Bicara Therapeutics Inc.
9.46
-5.21%
SMMT Summit Therapeutics Inc.
26.04
+1.56%
ASBP Aspire Biopharma Holdings, Inc.
0.7064
+199.58%
PRTA Prothena Corporation plc
4.6000
+0.44%
ITOS iTeos Therapeutics, Inc.
10.06
+17.94%